ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $5,905,000 | +1153.7% | 63,537 | +704.3% | 0.05% | +980.0% |
Q3 2021 | $471,000 | -41.2% | 7,900 | -24.2% | 0.01% | -54.5% |
Q4 2020 | $801,000 | -37.7% | 10,423 | -39.4% | 0.01% | -54.2% |
Q3 2020 | $1,286,000 | -57.0% | 17,197 | -73.5% | 0.02% | -82.0% |
Q3 2018 | $2,991,000 | +5.5% | 65,000 | 0.0% | 0.13% | -13.6% |
Q2 2018 | $2,834,000 | +377.9% | 65,000 | +333.3% | 0.15% | +250.0% |
Q1 2018 | $593,000 | – | 15,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |